Perspectives and Prospects
To give a tumour perspective is to consider both its impact on society and its impact on the patient. The estimated incidence of carcinoma of the prostate in the United Kingdom is 5,700 new cases per year (Tate et al. 1979); it is the sixth most common malignancy overall, but the commonest cancer of the male genito-urinary tract. In the United States there are 42,000 new cases per year and this tumour is the second most common cause of cancer deaths (Klein 1979). Despite such an incidence, carcinoma of the prostate is a malignancy which lacks popular image. Just as benign prostatic hyperplasia is often relegated to ‘only an old man’s problem’, so it is that the malignant prostate has little impact on general discussions on cancer. Indeed a number of tumours with a lower incidence have more appeal and, therefore, have larger resources devoted to them.
KeywordsProstatic Cancer Benign Prostatic Hyperplasia Radical Prostatectomy Testicular Tumour Deferred Treatment
Unable to display preview. Download preview PDF.
- Armenian HK, Lilienfeld AM, Diamond EL, Bross ID (1974) Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet 2: 15–117Google Scholar
- Axtell LM, Cutler SJ, Myers MH (eds) (1972) End results in cancer. Government Printing Office, Washington (Report no. 4, Department of Health, Education and Welfare; Publication no. (NIH) 73–272, National Cancer Institute)Google Scholar
- Byar DP (1977) VACURG studies on prostatic cancer and its treatment. In: Tannenbaum M (ed) Urologie pathology: the prostate. Lea & Febiger, New York, pp 241–267Google Scholar
- Chisholm GD (1980) Malignancy: prostate. In: Chisholm GD (ed) Tutorials in postgraduate medicine: urology. Heinemann, London, pp 223–246Google Scholar
- de Vere White R, Paulson DF, Glenn JF (1977) The clinical spectrum of prostate cancer. J Urol 117: 323–327Google Scholar
- Huggins C, Hodges CV (1941) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293–297Google Scholar
- Johnson DE, Hussey DH, Samuels ML (1980) Malignancy: testis. In: Chisholm GD (ed) Tutorials in postgraduate medicine: urology. Heinemann, London, pp 247–265Google Scholar
- Lasnitski I (1976) Action of hormones on the normal prostate and prostatic tumours grown in vitro. In: Williams DI, Chisholm GD (eds) Scientific foundations of urology. Heinamann, London, pp 365–370Google Scholar
- Lothian Health Board (1978) Annual statistical report. Lothian Health Board, EdinburghGoogle Scholar
- Schröder FH, Belt E (1975) Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 114: 257–267Google Scholar
- Zetterberg A, Esposti P-L (1976) Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma. Acta Cytol (Baltimore) 20: 46–57Google Scholar